In your Feb. 21 article titled “Challenges remain for biotech,” The Capital Times reviewed an interesting talk given at the University of Wisconsin last week by Steve Burrill, a venture capitalist who has created a very successful business focused on biotechnology investments. In the talk, Burrill presented his viewpoints on the biotech industry as an investment.
As a biotechnology industry advocate, scientist, and entrepreneur of over 20 years and as a father to three children, I found the article and Steve’s talk too pessimistic and narrow in scope.